Clindamycin Phosphate
Who holds supplier records for Clindamycin Phosphate? 12 organisations hold a current record for Clindamycin Phosphate: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (7), Italy (2), Spain (1) and India (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Clindamycin Phosphate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clindamycin-phosphate
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
7 of the 11 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Clindamycin Phosphate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ACS DOBFAR SPAItalyCEP Company GMP cert on recordActive DMF 18705 · latest filing Aug 2005
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChinaCEPActive DMF 16357 · latest filing Jan 2003
- Hubei Yitai Pharmaceutical Co., LtdChinaCEPActive DMF 32255 · latest filing Nov 2017
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPActive DMF 14412, 18533 · latest filing Jul 2005
- Xinyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 24358 · latest filing Nov 2010
- Zhejiang Tiantai Pharmaceutical Co., Ltd.ChinaCEPActive DMF 17422 · latest filing May 2004
- TRIFARMA SPAItaly Company GMP cert on recordActive DMF 12922 · latest filing Apr 1998
- ZHEJIANG CANDORLY PHARMACEUTICAL CO LTDActive DMF 13082 · latest filing Jul 1998
- Zhejiang Hisoar Pharmaceutical Co., Ltd.ChinaActive DMF 20937, 27271 · latest filing Jul 2013
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 26669 · latest filing Mar 2015
- TOPFOND PHARMACEUTICAL CO., LTD.ChinaCEP
- Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Clindamycin Phosphate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| XINYU PHARMACEUTICAL CO., LTD. Suzhou | CN | CEP 2011-019 - Rev 03 Clindamycin phosphate | Feb 2026 | — |
| TOPFOND PHARMACEUTICAL CO., LTD. Zhumadian | CN | CEP 2023-082 - Rev 00 Clindamycin phosphate | Aug 2025 | — |
| HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen | CN | CEP 2022-145 - Rev 01 Clindamycin phosphate | May 2025 | — |
| ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2013-178 - Rev 02 Clindamycin phosphate, BTC process | Oct 2024 | Inspected Jan 2024 Germany |
| ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2003-060 - Rev 07 Clindamycin phosphate | Mar 2024 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R1-CEP 2000-097 - Rev 05 Clindamycin phosphate | Jun 2023 | — |
| Chongqing Carelife Pharmaceutical Co. Ltd. Chongqing | CN | R1-CEP 2005-033 - Rev 03 Clindamycin phosphate | Jan 2023 | — |
| ACS DOBFAR S.P.A. Tribiano | IT | R1-CEP 2006-033 - Rev 04 Clindamycin phosphate, Albano plant | Sept 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Clindamycin Phosphate are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- ZHEJIANG WEPON PHARMACEUTICAL CO LTDInactive DMF 19741 · filed May 2006
- China · Inactive DMF 17052 · filed Dec 2003
- SUZHOU NUMBER 4 PHARMACEUTICAL FACTORYInactive DMF 16225 · filed Nov 2002
- United States · Inactive DMF 15290 · filed Feb 2001
- ZHEJIANG TAIZHOU HISOAR PHARM CHEM CO LTDInactive DMF 14797 · filed Mar 2000
- United States · Inactive DMF 13499 · filed Sept 1998
- ROUSSELL UCLAFInactive DMF 13705 · filed Sept 1998
- United States · Inactive DMF 13725 · filed Sept 1998
- Canada · Inactive DMF 7193, 13729 · filed Sept 1998
- United States · Inactive DMF 13703 · filed Sept 1998
- AMERICAN CHEMICAL INDUSTRIAL CORPInactive DMF 7359 · filed Feb 1988
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Clindamycin Phosphate is a water-soluble ester of clindamycin used as an antibiotic for the treatment of anaerobic bacterial infections. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth.
Chemical identity
- IUPAC name
- [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
- Canonical SMILES
- CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@H](C)Cl
- InChIKey
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N
- Synonyms
- Cleocin API, acanya component clindamycin phosphate, cabtreo component clindamycin phosphate, cleocin, cleocin phosphate, cleocin t, clinadac, clinda-derm, clindac, clindagel, clindamycin (as phosphate), clindamycin 2-dihydrogen phosphate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Lincosamide Antibacterial
- Physiologic effect
- Decreased Sebaceous Gland Activity; Neuromuscular Blockade
- Chemical structure
- Lincosamides
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Clindamycin Phosphate?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Clindamycin Phosphate: ACS DOBFAR SPA (Italy), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Hubei Yitai Pharmaceutical Co., Ltd (China), UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (Spain), Xinyu Pharmaceutical Co., Ltd. (China), Zhejiang Tiantai Pharmaceutical Co., Ltd. (China), TRIFARMA SPA (Italy) and ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Clindamycin Phosphate Drug Master Files are active?
ACS DOBFAR SPA (DMF 18705), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 16357), Hubei Yitai Pharmaceutical Co., Ltd (DMF 32255), UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (DMF 14412, 18533), Xinyu Pharmaceutical Co., Ltd. (DMF 24358), Zhejiang Tiantai Pharmaceutical Co., Ltd. (DMF 17422), TRIFARMA SPA (DMF 12922) and ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD (DMF 13082) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Clindamycin Phosphate records mean?
11 organisations have only inactive Type II DMFs for Clindamycin Phosphate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Clindamycin Phosphate have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Clindamycin Phosphate on the EDQM register, including XINYU PHARMACEUTICAL CO., LTD. Suzhou (CN), TOPFOND PHARMACEUTICAL CO., LTD. Zhumadian (CN), HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen (CN), ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City (CN), ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City (CN) and Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona (ES) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Clindamycin Phosphate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Clindamycin Phosphate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.